EHV · Next-Generation Pharma Tech
Backing Founders Building
Next-Generation Pharma Tech and Services
EHV is a sector-focused venture fund investing in B2B Pharma Tech and tech-enabled pharma services. We partner with capital-efficient seed and Series A companies and help them access customers, strategic partners, advisors, and acquirers across pharma, providers, and payers.
AI-Powered Pharma Tech
Focused capital. Strategic access.
Research Triangle Park, NC
B2B SaaS Healthcare
19 Investments
8 Exits
Founder-First
Network-Led
AI-Powered Pharma Tech
Focused capital. Strategic access.
Research Triangle Park, NC
B2B SaaS Healthcare
19 Investments
8 Exits
Founder-First
Network-Led
Our thesis
Pharma Tech is the evolutionary progression of healthcare software and it is where we invest
01
AI-Powered Pharma Tech
We back the next generation of software and tech-enabled services that vastly improve time to market and effectiveness within the Pharmaceutical industry.
02
Capital-efficient B2B SaaS
We invest in SaaS and tech-enabled services with large markets and defensible moats, proprietary tech, data flywheels, or network effects.
03
Investors are your customers
Our investors are pharma, provider, and payer decision-makers, your potential customers and acquirers, turning network access into commercial traction.
From one entrepreneur to another
“In addition to our deep experience in healthcare and venture capital, we bring scientific, business, financial, IP, and start-up experience that benefits our portfolio companies and co-investors.”— EHV Management